
    
      The system will be evaluated on up to 21 pregnant adult subjects with type 1 diabetes age
      18-45 years old at three clinical sites (Sansum Diabetes Research Institute, Mayo Clinic
      Rochester MN and Mt Sinai Hospital, New York City). Subjects will complete a 48-60 hour
      closed-loop (CL) session in a supervised outpatient environment with medical staff present.
      During the session, subjects will bolus for all meals and snacks, and will perform their
      usual daily activities while being accompanied by study medical staff.
    
  